Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: early results of a Phase III randomized trial.
Evidence for efficacy of hypofractionated radiotherapy for prostate cancer without increased toxicity: early results of a randomized phase III trial.